COMMUNIQUÉS West-GlobeNewswire

InnovAge Celebrates Grand Opening of Orlando’s First PACE Center in Partnership with Orlando Health
29/05/2024
PACE Program Provides Highly Coordinated, Personalized Senior Care ORLANDO, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive [...]
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
29/05/2024
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 29 May, 2024, 6pm CET AB Science SA (Euronext [...]
AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA
29/05/2024
COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE D'AUTORISATION CONDITIONNELLE DE MISE SUR LE MARCHÉ DU MASITINIB DANS LE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE Paris, 29 mai 2024, 18h AB Science [...]
Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 19 juin 2024
29/05/2024
Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 19 juin 2024 Nantes, le 29 mai 2024, 18 heures – OSE Immunotherapeutics SA ( ISIN: FR0012127173; Mnémo: OSE) annonce la mise en ligne des [...]
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
29/05/2024
Press release – No. 5 / 2024 Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024 Copenhagen, Denmark, May 29, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a [...]
BioStem Technologies to Sponsor MRO Better Half Dash
29/05/2024
POMPANO BEACH, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived [...]
Twin Cities Lyme Foundation and Bay Area Lyme Foundation Unite Efforts to Further Advance the Fight Against Tick-Borne Diseases
29/05/2024
Twin Cities Lyme Foundation Founder Lisa Najarian and her husband Former CNBC Correspondent Peter Najarian to join the Advisory Board of Bay Area Lyme Foundation PORTOLA VALLEY, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- [...]
Trading by management and close relations of management
29/05/2024
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of [...]
UPDATE -- Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch
29/05/2024
Georgiamune receives U.S. FDA clearance for GIM-531 and continues to enroll patients in clinical trial testing for GIM-122 GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc. , a privately held, [...]
AMN Healthcare Launches Market Insights into ShiftWise Flex: Empowering Healthcare Talent Strategy with Dynamic Intelligence
29/05/2024
DALLAS, May 29, 2024 (GLOBE NEWSWIRE) -- ShiftWise Flex, a next-gen vendor neutral vendor management system (VMS) that serves as a comprehensive workforce management platform for healthcare organizations, announces the [...]
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
29/05/2024
BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced new preliminary data [...]
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology
29/05/2024
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology Paris, 29 May 2024 - Dedicated to the research of new immunotherapeutic vaccines [...]
Parents Pay Tribute to Daughter's Legacy by Giving Back to LHSC Trauma Team
29/05/2024
LONDON, Ontario, May 29, 2024 (GLOBE NEWSWIRE) -- For several years, Lisa and Dennis Carroll have dedicated their lives to honouring the memory of their daughter Rachel. Their journey is marked by showcasing the [...]
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
29/05/2024
SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune [...]
Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer
29/05/2024
Brings over two decades of biopharmaceutical legal, compliance and leadership experience CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced that Eric L. Trachtenberg, J.D., M [...]
Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch
29/05/2024
Georgiamune receives U.S. FDA clearance for GIM-531 and begins phase II of clinical trial testing for GIM-122 GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc. , a privately held, clinical- [...]
Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
29/05/2024
-- Reimbursement at $23,900, slightly below list price -- -- Represents a significant milestone toward increasing accessibility of PoNS -- NEWTOWN, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc [...]
TerrAscend Celebrates the Opening of its New Detroit Dispensary, GAGE 313
29/05/2024
GAGE 313 is the company’s 20th Michigan dispensary TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today [...]
Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update
29/05/2024
– Q1 2024 marked by significant advancement of R&D projects focused on avenanthramide Phase 1-2a clinical study and the processing of yeast beta glucan along with the building of pilot scale units for PGX Technology [...]

Pages